Published on 23 Feb 2024 on Simply Wall St. via Yahoo Finance
Fresenius Medical Care AG (ETR:FME) Just Released Its Full-Year Results And Analysts Are Updating...
Shareholders might have noticed that Fresenius Medical Care AG (ETR:FME) filed its full-year result this time last week. The early response was not positive, with shares down 7.5% to €35.90 in the past week. Fresenius Medical Care reported in line with analyst predictions, delivering revenues of €19b and statutory earnings per share of €1.70, suggesting the business is executing well and in line with its plan. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.
Check out our latest analysis for Fresenius Medical Care
